ROYE yields 400.00% · PFE yields 6.13%● Live data
📍 ROYE pulled ahead of the other in Year 1
Combined, ROYE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROYE + PFE for your $10,000?
Royal Energy Resources, Inc. produces and markets coal from surface and underground mines located in Kentucky, Ohio, Utah, and West Virginia in the United States. The company provides coal of various steam and metallurgical grades, including steam coal primarily to electric utility companies as fuel for their steam powered generators; and metallurgical coal for steel and coke producers who use its coal to produce coke. As of December 31, 2018, it had an estimated 268.5 million tons of proven and probable coal reserves consisting of an estimated 214.0 million tons of steam coal and an estimated 54.5 million tons of metallurgical coal. The company was formerly known as World Marketing, Inc. and changed its name to Royal Energy Resources, Inc. in December 2007. Royal Energy Resources, Inc. was incorporated in 1999 and is headquartered in Charleston, South Carolina. Royal Energy Resources, Inc. is a subsidiary of E-Starts Money Co.
Full ROYE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.